DelMar Pharmaceuticals, Inc.

DelMar Pharmaceuticals, Inc.verified

DMPWW

Price:

$0.0001

Market Cap:

$52.17M

Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intrinsic pontine glioma; and REM-001, a late stage photodynamic therapy for the treatment of cutaneous metastatic breast cancer, basal cell carcinoma nevus syndrome, and access graft failure in hemodialysis patients. Kintara Therapeutics, Inc. has a stra...[Read more]

Industry

Biotechnology

IPO Date

Stock Exchange

OTC

Ticker

DMPWW

The PE Ratio as of December 2025 (TTM) for DelMar Pharmaceuticals, Inc. (DMPWW) is -0.00

According to DelMar Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.00. This represents a change of -100.00% compared to the average of -169.16 of the last 4 quarters.

DelMar Pharmaceuticals, Inc. (DMPWW) Historical PE Ratio (quarterly & annually)

How has DMPWW PE Ratio performed in the past?

The mean historical PE Ratio of DelMar Pharmaceuticals, Inc. over the last ten years is -0.43. The current -0.00 PE Ratio has changed -99.29% with respect to the historical average. Over the past ten years (40 quarters), DMPWW's PE Ratio was at its highest in in the June 2024 quarter at 0. The PE Ratio was at its lowest in in the September 2024 quarter at -666.80.

Quarterly (TTM)
Annual

Average

-0.43

Median

-0.07

Minimum

-3.52

Maximum

-0.01

DelMar Pharmaceuticals, Inc. (DMPWW) PE Ratio by Quarter and Year

Discovering the peaks and valleys of DelMar Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 2.36%

Maximum Annual PE Ratio = -0.01

Minimum Annual Increase = -67.99%

Minimum Annual PE Ratio = -3.52

Quarterly (TTM)
Annual
YearPE RatioChange
2024-3.522.36%
2023-0.14320.19%
2022-0.03-66.34%
2021-0.10130.73%
2021-0.0494.85%
2020-0.0292.32%
2019-0.01-67.99%
2018-0.04-62.53%
2017-0.10-64.79%
2016-0.2871.14%

DelMar Pharmaceuticals, Inc. (DMPWW) Average PE Ratio

How has DMPWW PE Ratio performed in the past?

The current PE Ratio of DelMar Pharmaceuticals, Inc. (DMPWW) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-1.23

5-year avg

-0.77

10-year avg

-0.43

DelMar Pharmaceuticals, Inc. (DMPWW) PE Ratio vs. Peers

How is DMPWW’s PE Ratio compared to its peers?

DelMar Pharmaceuticals, Inc.’s PE Ratio is greater than Kiromic BioPharma, Inc. (-0.11), greater than Hemogenyx Pharmaceuticals Plc (-7.47), greater than Vitalibis, Inc. (-0.00), greater than Evome Medical Technologies Inc. (-2.20), greater than ProSomnus, Inc. (-0.32), less than Advanced Proteome Therapeutics Corporation (0.01), greater than CuraScientific Corp (-0.00), greater than TRACON Pharmaceuticals, Inc. (-0.01), greater than Molecular Templates, Inc. (-0.00), greater than Predictive Technology Group, Inc. (-0.00),

Build a custom stock screener for DelMar Pharmaceuticals, Inc. (DMPWW) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like DelMar Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

DelMar Pharmaceuticals, Inc. (DMPWW) and other stocks custom spreadsheet templates

The easiest way to analyze a company like DelMar Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is DelMar Pharmaceuticals, Inc.'s PE Ratio?

How is the PE Ratio calculated for DelMar Pharmaceuticals, Inc. (DMPWW)?

What is the highest PE Ratio for DelMar Pharmaceuticals, Inc. (DMPWW)?

What is the 3-year average PE Ratio for DelMar Pharmaceuticals, Inc. (DMPWW)?

What is the 5-year average PE Ratio for DelMar Pharmaceuticals, Inc. (DMPWW)?

How does the current PE Ratio for DelMar Pharmaceuticals, Inc. (DMPWW) compare to its historical average?